EQL Pharma AB (publ) announced that its annual general meeting held on 17 August 2021 elected Per Ollermark and Per Svangren as new members of the board of directors for the period until the end of the next annual general meeting. And announced that Lars Holmqvist and Maria Bech had declined re-election as board members.